Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001831283-23-000051
Filing Date
2023-03-31
Accepted
2023-03-31 16:17:19
Documents
1
Period of Report
2023-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_168029382182313.html 4  
1 FORM 4 wf-form4_168029382182313.xml 4 3680
  Complete submission text file 0001831283-23-000051.txt   5073
Mailing Address C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, STE. 200 SAN DIEGO CA 92121
Business Address
Larson Yi (Reporting) CIK: 0001785987 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40947 | Film No.: 23787953

Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Issuer) CIK: 0001831283 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations